chr19-10513834-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PVS1_ModerateBP6_Very_StrongBS2
The NM_030760.5(S1PR5):āc.1178C>Gā(p.Ser393Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000402 in 1,612,870 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0021 ( 4 hom., cov: 33)
Exomes š: 0.00023 ( 1 hom. )
Consequence
S1PR5
NM_030760.5 stop_gained
NM_030760.5 stop_gained
Scores
1
1
5
Clinical Significance
Conservation
PhyloP100: 0.717
Genes affected
S1PR5 (HGNC:14299): (sphingosine-1-phosphate receptor 5) The lysosphingolipid sphingosine 1-phosphate (S1P) regulates cell proliferation, apoptosis, motility, and neurite retraction. Its actions may be both intracellular as a second messenger and extracellular as a receptor ligand. S1P and the structurally related lysolipid mediator lysophosphatidic acid (LPA) signal cells through a set of G protein-coupled receptors known as EDG receptors. Some EDG receptors (e.g., EDG1; MIM 601974) are S1P receptors; others (e.g., EDG2; MIM 602282) are LPA receptors.[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0159 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BP6
Variant 19-10513834-G-C is Benign according to our data. Variant chr19-10513834-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 788017.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
S1PR5 | NM_030760.5 | c.1178C>G | p.Ser393Ter | stop_gained | 2/2 | ENST00000333430.6 | |
S1PR5 | NM_001166215.2 | c.1178C>G | p.Ser393Ter | stop_gained | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
S1PR5 | ENST00000333430.6 | c.1178C>G | p.Ser393Ter | stop_gained | 2/2 | 1 | NM_030760.5 | P1 | |
S1PR5 | ENST00000439028.3 | c.1178C>G | p.Ser393Ter | stop_gained | 2/2 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00208 AC: 316AN: 152240Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
316
AN:
152240
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000560 AC: 139AN: 248124Hom.: 2 AF XY: 0.000416 AC XY: 56AN XY: 134708
GnomAD3 exomes
AF:
AC:
139
AN:
248124
Hom.:
AF XY:
AC XY:
56
AN XY:
134708
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000229 AC: 334AN: 1460512Hom.: 1 Cov.: 29 AF XY: 0.000201 AC XY: 146AN XY: 726576
GnomAD4 exome
AF:
AC:
334
AN:
1460512
Hom.:
Cov.:
29
AF XY:
AC XY:
146
AN XY:
726576
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00206 AC: 314AN: 152358Hom.: 4 Cov.: 33 AF XY: 0.00199 AC XY: 148AN XY: 74510
GnomAD4 genome
AF:
AC:
314
AN:
152358
Hom.:
Cov.:
33
AF XY:
AC XY:
148
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
41
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
87
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 16, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
N;N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at